Annual EBIT:
-$104.55M-$21.02M(-25.17%)Summary
- As of today, ELVN annual earnings before interest & taxes is -$104.55 million, with the most recent change of -$21.02 million (-25.17%) on December 31, 2024.
- During the last 3 years, ELVN annual EBIT has fallen by -$79.79 million (-322.24%).
- ELVN annual EBIT is now -1074.10% below its all-time high of -$8.90 million, reached on December 1, 2017.
Performance
ELVN EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBIT:
-$25.10M+$3.49M(+12.20%)Summary
- As of today, ELVN quarterly earnings before interest & taxes is -$25.10 million, with the most recent change of +$3.49 million (+12.20%) on September 30, 2025.
- Over the past year, ELVN quarterly EBIT has increased by +$1.97 million (+7.29%).
- ELVN quarterly EBIT is now -670.53% below its all-time high of -$3.26 million, reached on December 31, 2022.
Performance
ELVN Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
-$112.27M+$1.97M(+1.73%)Summary
- As of today, ELVN TTM earnings before interest & taxes is -$112.27 million, with the most recent change of +$1.97 million (+1.73%) on September 30, 2025.
- Over the past year, ELVN TTM EBIT has dropped by -$11.88 million (-11.84%).
- ELVN TTM EBIT is now -1531.34% below its all-time high of -$6.88 million, reached on September 1, 2019.
Performance
ELVN TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
ELVN EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -25.2% | +7.3% | -11.8% |
| 3Y3 Years | -322.2% | -129.5% | -161.3% |
| 5Y5 Years | -333.6% | -100.9% | -272.4% |
ELVN EBIT Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -322.2% | at low | -670.5% | +20.8% | -252.1% | +1.7% |
| 5Y | 5-Year | -333.6% | at low | -670.5% | +20.8% | -272.4% | +1.7% |
| All-Time | All-Time | -1074.1% | at low | -670.5% | +20.8% | -1531.3% | +1.7% |
ELVN EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | -$25.10M(+12.2%) | -$112.27M(+1.7%) |
| Jun 2025 | - | -$28.58M(+9.8%) | -$114.24M(-3.6%) |
| Mar 2025 | - | -$31.69M(-17.8%) | -$110.26M(-5.5%) |
| Dec 2024 | -$104.55M(-25.2%) | -$26.90M(+0.6%) | -$104.55M(-4.2%) |
| Sep 2024 | - | -$27.07M(-10.0%) | -$100.39M(-2.9%) |
| Jun 2024 | - | -$24.60M(+5.3%) | -$97.57M(-4.8%) |
| Mar 2024 | - | -$25.99M(-14.3%) | -$93.10M(-11.5%) |
| Dec 2023 | -$83.53M(-143.7%) | -$22.73M(+6.3%) | -$83.53M(-30.4%) |
| Sep 2023 | - | -$24.25M(-20.4%) | -$64.06M(-26.2%) |
| Jun 2023 | - | -$20.13M(-22.6%) | -$50.74M(-28.1%) |
| Mar 2023 | - | -$16.42M(-404.1%) | -$39.63M(-24.3%) |
| Dec 2022 | -$34.27M | -$3.26M(+70.2%) | -$31.89M(+25.8%) |
| Sep 2022 | - | -$10.93M(-21.3%) | -$42.96M(+6.0%) |
| Jun 2022 | - | -$9.02M(-3.9%) | -$45.69M(+8.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$8.68M(+39.5%) | -$49.84M(+3.1%) |
| Dec 2021 | -$24.76M(+40.6%) | - | - |
| Dec 2021 | - | -$14.33M(-4.9%) | -$51.44M(-5.7%) |
| Sep 2021 | - | -$13.66M(-3.7%) | -$48.66M(-2.5%) |
| Jun 2021 | - | -$13.17M(-28.1%) | -$47.49M(-6.4%) |
| Mar 2021 | - | -$10.28M(+11.0%) | -$44.63M(-7.0%) |
| Dec 2020 | -$41.70M(-72.9%) | -$11.55M(+7.6%) | -$41.70M(-38.3%) |
| Sep 2020 | - | -$12.49M(-21.3%) | -$30.15M(-22.9%) |
| Jun 2020 | - | -$10.30M(-40.1%) | -$24.54M(-72.4%) |
| Mar 2020 | - | -$7.35M(-6.8%) | -$14.23M(-106.8%) |
| Dec 2019 | -$24.12M(-125.9%) | - | - |
| Sep 2019 | - | -$6.88M | -$6.88M |
| Dec 2018 | -$10.68M(-19.9%) | - | - |
| Dec 2017 | -$8.90M | - | - |
FAQ
- What is Enliven Therapeutics, Inc. annual earnings before interest & taxes?
- What is the all-time high annual EBIT for Enliven Therapeutics, Inc.?
- What is Enliven Therapeutics, Inc. annual EBIT year-on-year change?
- What is Enliven Therapeutics, Inc. quarterly earnings before interest & taxes?
- What is the all-time high quarterly EBIT for Enliven Therapeutics, Inc.?
- What is Enliven Therapeutics, Inc. quarterly EBIT year-on-year change?
- What is Enliven Therapeutics, Inc. TTM earnings before interest & taxes?
- What is the all-time high TTM EBIT for Enliven Therapeutics, Inc.?
- What is Enliven Therapeutics, Inc. TTM EBIT year-on-year change?
What is Enliven Therapeutics, Inc. annual earnings before interest & taxes?
The current annual EBIT of ELVN is -$104.55M
What is the all-time high annual EBIT for Enliven Therapeutics, Inc.?
Enliven Therapeutics, Inc. all-time high annual earnings before interest & taxes is -$8.90M
What is Enliven Therapeutics, Inc. annual EBIT year-on-year change?
Over the past year, ELVN annual earnings before interest & taxes has changed by -$21.02M (-25.17%)
What is Enliven Therapeutics, Inc. quarterly earnings before interest & taxes?
The current quarterly EBIT of ELVN is -$25.10M
What is the all-time high quarterly EBIT for Enliven Therapeutics, Inc.?
Enliven Therapeutics, Inc. all-time high quarterly earnings before interest & taxes is -$3.26M
What is Enliven Therapeutics, Inc. quarterly EBIT year-on-year change?
Over the past year, ELVN quarterly earnings before interest & taxes has changed by +$1.97M (+7.29%)
What is Enliven Therapeutics, Inc. TTM earnings before interest & taxes?
The current TTM EBIT of ELVN is -$112.27M
What is the all-time high TTM EBIT for Enliven Therapeutics, Inc.?
Enliven Therapeutics, Inc. all-time high TTM earnings before interest & taxes is -$6.88M
What is Enliven Therapeutics, Inc. TTM EBIT year-on-year change?
Over the past year, ELVN TTM earnings before interest & taxes has changed by -$11.88M (-11.84%)